loader
Please Wait
Applying Filters...

Suanfarma Suanfarma

X

List of Certificates of Suitability (CEPs) for r0_cep_2014_363___rev_00 Active Pharmaceutical Ingredient (API) issued by the EDQM. Original Data: EDQM Database

Client Virtual Booth
Menu
Filters Filter
Cross PopUp
FILTER :

filter

01 MEDINEX LABORATORIES PRIVATE LIMITED Mumbai IN (1)

filter

01 Noradrenaline tartrate (1)

filter

01 India (1)

filter

01 Withdrawn by EDQM Failure to CEP procedure (1)

URL Supplier Web Content
R0-CEP 2014-363 - Rev 00
Withdrawn by EDQM F...
Chemical
2017-01-09
2018-02-20
285
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Looking for Certificates of Suitability (CEPs) for R0-CEP 2014-363 - Rev 00 of Medinex Laboratories Private Limited Mumbai In

Looking for Certificates of Suitability (CEPs) for R0-CEP 2014-363 - Rev 00 of Medinex Laboratories Private Limited Mumbai In 1

20

Medinex Laboratories Private Limited Mumbai In, based in India, is a pharmaceutical company that stands out with its certifications from FDA and WHO-GMP.

They are recognized for Medinex Group specializes in the manufacture of Adrenaline based niche APIs.

One of their significant offerings is Noradrenaline tartrate, supported by a 'Withdrawn by EDQM Failure to CEP procedure' Certificate of Suitability (CEP) with the number R0-CEP 2014-363 - Rev 00

This Chemical Type CEP, issued on January 09, 2017, remains in force until February 20, 2018, ensuring its reliability within the pharmaceutical industry.

Substance Number 285 associated with this CEP further emphasizes

Post Enquiry
POST ENQUIRY